{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:40:29Z","timestamp":1789371629357,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Major Scientific and Technological Special Project","award":["2013ZX09103003-011"],"award-info":[{"award-number":["2013ZX09103003-011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.intimp.2017.02.023","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T23:27:18Z","timestamp":1488497238000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Enhanced humoral and CD8 + T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-1011","authenticated-orcid":false,"given":"Ying","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ying","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9725","key":"10.1016\/j.intimp.2017.02.023_bb0005","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"9181","key":"10.1016\/j.intimp.2017.02.023_bb0010","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(99)80040-3","article-title":"Respiratory syncytial virus infection","volume":"354","author":"Simoes","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2017.02.023_bb0015","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14787210.3.5.719","article-title":"Palivizumab in the prophylaxis of respiratory syncytial virus infection","volume":"3","author":"Cardenas","year":"2005","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"6136","key":"10.1016\/j.intimp.2017.02.023_bb0020","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.intimp.2017.02.023_bb0025","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1073\/pnas.81.24.7683","article-title":"Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus","volume":"81","author":"Collins","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2017.02.023_bb0030","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/187152612800100143","article-title":"Targeting RSV with vaccines and small molecule drugs","volume":"12","author":"Costello","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2017.02.023_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/JVI.47.1.171-177.1983","article-title":"Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein","volume":"47","author":"Walsh","year":"1983","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.intimp.2017.02.023_bb0040","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies","volume":"62","author":"Anderson","year":"1988","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2017.02.023_bb0045","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"Collins","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2017.02.023_bb0050","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2017.02.023_bb0055","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2017.02.023_bb0060","first-page":"17","article-title":"Dendritic cells: translating innate to adaptive immunity","volume":"311","author":"Steinman","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2017.02.023_bb0065","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ni880","article-title":"Functional interactions between dendritic cells and NK cells during viral infection","volume":"4","author":"Andrews","year":"2003","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2017.02.023_bb0070","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.20032220","article-title":"In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination","volume":"199","author":"Bonifaz","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2017.02.023_bb0075","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.20052005","article-title":"Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine","volume":"203","author":"Trumpfheller","year":"2006","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2017.02.023_bb0080","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1172\/JCI34224","article-title":"The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells","volume":"118","author":"Nchinda","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2017.02.023_bb0085","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.4049\/jimmunol.179.8.5415","article-title":"CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"179","author":"Olson","year":"2007","journal-title":"J. Immunol."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2017.02.023_bb0090","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1099\/vir.0.058461-0","article-title":"Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation","volume":"95","author":"Garg","year":"2014","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2017.02.023_bb0095","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2017.02.023_bb0100","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2017.02.023_bb0105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.imlet.2016.09.011","article-title":"DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice","volume":"179","author":"Hua","year":"2016","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2017.02.023_bb0110","first-page":"147","article-title":"Research on the methods for titrating respiratory syncytial virus","volume":"24","author":"Wang","year":"2010","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.intimp.2017.02.023_bb0115","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/JVI.02036-10","article-title":"Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice","volume":"85","author":"Maamary","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2017.02.023_bb0120","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2017.02.023_bb0125","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1074\/jbc.M110.191437","article-title":"T cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection","volume":"286","author":"Billam","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.02.023_bb0130","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2172-10-43","article-title":"Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands","volume":"10","author":"Grossmann","year":"2009","journal-title":"BMC Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2017.02.023_bb0135","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.vaccine.2015.11.069","article-title":"Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells","volume":"34","author":"Jing","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2017.02.023_bb0140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","article-title":"Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens","volume":"199","author":"Heath","year":"2004","journal-title":"Immunol. Rev."},{"issue":"13","key":"10.1016\/j.intimp.2017.02.023_bb0145","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1182\/blood-2010-02-268425","article-title":"Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation","volume":"116","author":"Birkholz","year":"2010","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917300784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917300784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T09:16:15Z","timestamp":1601716575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917300784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"alternative-id":["S1567576917300784"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.02.023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}